Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients With Advanced Solid Tumors or Lymphoma
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-0822
Full Text
Open PDFAbstract
Available in full text
Date
June 10, 2010
Authors
Publisher
American Association for Cancer Research (AACR)